Anti-Clotting Effect of Aspirin Wanes Over Time
Posted on 2004-03-26 03:56:00 in
Cardio-Vascular |
NEW YORK (Reuters Health) - Aspirin is widely used to prevent platelets in the blood clumping together and forming clots, but physicians in Rome report that aspirin's anti-platelet action declines with prolonged treatment.
However, this is not seen with another anti-clotting drug called ticlopidine, also known as Ticlid.
Previous research has suggested a progressive decrease in aspirin's clinical efficacy after two years of treatment, Dr. Fabio M. Pulcinelli and his associates explain in the Journal of the American College of Cardiology. To investigate further, the research team at the University "La Sapienza" monitored blood samples from 150 patients for two years after they started anti-platelet treatment.
In the lab, the maximal percentage of platelets that could be made to clump together decreased from 88 percent at the start of the study to 38 percent after two months. Thereafter, clumping increased progressively to 46 percent at 6 months, 48 percent at 12 months and 62 percent at 24 months.
In contrast, in a group of 80 similar patients, the anti-platelet effects of ticlopidine did not change significantly during two years of treatment.
The authors point out that other researchers have observed a reduction in cardiovascular events when treatment with aspirin was combined with clopidogrel, another anti-platelet agent.
"Future studies should therefore address the question of whether the superiority of such a combination is dependent on a more complete and efficient inhibition of platelet aggregation or on a protective effect provided by clopidogrel in patients with a progressively reduced sensitivity to aspirin," Pulcinelli's team concludes.
SOURCE: Journal of the American College of Cardiology, March 17, 2004.
However, this is not seen with another anti-clotting drug called ticlopidine, also known as Ticlid.
Previous research has suggested a progressive decrease in aspirin's clinical efficacy after two years of treatment, Dr. Fabio M. Pulcinelli and his associates explain in the Journal of the American College of Cardiology. To investigate further, the research team at the University "La Sapienza" monitored blood samples from 150 patients for two years after they started anti-platelet treatment.
In the lab, the maximal percentage of platelets that could be made to clump together decreased from 88 percent at the start of the study to 38 percent after two months. Thereafter, clumping increased progressively to 46 percent at 6 months, 48 percent at 12 months and 62 percent at 24 months.
In contrast, in a group of 80 similar patients, the anti-platelet effects of ticlopidine did not change significantly during two years of treatment.
The authors point out that other researchers have observed a reduction in cardiovascular events when treatment with aspirin was combined with clopidogrel, another anti-platelet agent.
"Future studies should therefore address the question of whether the superiority of such a combination is dependent on a more complete and efficient inhibition of platelet aggregation or on a protective effect provided by clopidogrel in patients with a progressively reduced sensitivity to aspirin," Pulcinelli's team concludes.
SOURCE: Journal of the American College of Cardiology, March 17, 2004.
Health Headlines MORE »
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
First-of-its-kind study reports that indoor air in offices is an important source of worker exposure to potentially toxic substances.
Twenty percent of Americans ages 18+ experienced a diagnosable mental, behavioral, or emotional disorder in 2010.
ANTI-AGING TIP OF THE DAY
A Bright Future
University of Southern Denmark researchers report that more than half of the babies born today in developed countries will live to be 100, and the extended lifespan will likely come with fewer disabilities and limitations. Writing that: “If the pace of increase in life expectancy in developed countries over the past two centuries continues through the 21st century...
»
MORE
